Stephen J. Schueler, M.D.

Overview Symptoms Evaluation Treatment specialist Home Care abdominal pain liver diet vomiting warning signs Underlying Cause diseases drugs

Yellow Skin Drugs

Last Updated: Dec 16, 2010 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Yellow Skin References
  1. Ahlfors CE, Wennberg RP. Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol. 2004 Oct;28(5):334-9. [15686264]
  2. Moyer V, Freese DK, Whitington PF, Olson AD, Brewer F, Colletti RB, Heyman MB; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):115-28. [15269615]
  3. Pitiakoudis M, Mimidis K, Tsaroucha AK, Papadopoulos V, Karayiannakis A, Simopoulos C. Predictive value of risk factors in patients with obstructive jaundice. J Int Med Res. 2004 Nov-Dec;32(6):633-8. [15587757]
  4. Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004 Jan 15;69(2):299-304. [14765767]
  5. Szabo P, Wolf M, Bucher HU, Haensse D, Fauchere JC, Arlettaz R. Assessment of jaundice in preterm neonates: comparison between clinical assessment, two transcutaneous bilirubinometers and serum bilirubin values. Acta Paediatr. 2004 Nov;93(11):1491-5. [15513578]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.